All data are based on the daily closing price as of June 6, 2025
b
BioNote
377740.KO
3.75 USD
0.03
+0.81%
Overview
Last close
3.75 usd
Market cap
380.27M usd
52 week high
4.56 usd
52 week low
2.83 usd
Target price
4.19 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
4.8806
Price/Book Value
0.3189
Enterprise Value
97.67M usd
EV/Revenue
1.2534
EV/EBITDA
2.0445
Key financials
Revenue TTM
77.93M usd
Gross Profit TTM
39.38M usd
EBITDA TTM
16.00M usd
Earnings per Share
N/A usd
Dividend
0.15 usd
Total assets
1.33B usd
Net debt
N/A usd
About
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.